Quintiles and Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) has signed an agreement to accelerate the development of new medicines.
SCPMG will join Quintile’s prime sites in the University of Pretoria, South Africa; Queen Mary’s College in London, UK; and the Washington Hospital Center in Washington DC, US, to carry out clinical research.
Quintiles said biopharmaceutical companies are expected to benefit from the collaboration as the partners offer clinical and research expertise, thereby reducing complexity and accelerating trials.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData